Bristol-Myers Squibb Stock: Look For The Exit (NYSE:BMY)
Drew Angerer/Getty Images News After successfully absorbing the Celgene deal, Bristol-Myers Squibb (NYSE:BMY) has jumped to new all-time highs. The large cash deal to buy Turning Point (TPTX) suggests the company no longer sees the […]
